Skip to content

Shattuck Labs, Inc. STTK Shares (Diluted)

Shares (Diluted) at other companies

Eli Lilly logo
Eli LillyLLY
895.9M-0.5%
Johnson & Johnson logo
Johnson & JohnsonJNJ
2.4B+0.9%
Amgen logo
AmgenAMGN
544M+0.6%
AbbVie logo
AbbVieABBV
1.8B+0.1%
Aclaris Therapeutics logo
Aclaris TherapeuticsACRS
128.8M+5.2%
Avalo Therapeutics logo
Avalo TherapeuticsAVTX
20.1M+91.2%

Other financials

Income statement

See full
Revenue-
Operating income-$15.5M-8.0%
Net income-$14.8M-7.8%
EPS (diluted)-$0.13+51.9%

Balance sheet

See full
Cash & equivalents$90.4M+48.5%
Total debt$2.9M-9.5%
Total equity$95.8M+41.8%
Total assets$102.1M+32.3%

Cash flow

See full
Operating cash flow-$13.4M-11.6%
CapEx$63.0K
Free cash flow-$13.5M-12.1%

Valuation

See full
Market cap$564.45M+1,131%
Enterprise value$476.92M-4,119%
P/S564.5×+554×

Profitability

See full
Operating margin-5,266.4%-9,520pp
Net margin-4,987.4%-8,966pp
FCF margin-4,140.8%-7,144pp

Returns & leverage

See full
Return on equity-61%-8.0pp
Debt / equity0.0×
Current ratio22.1×+13.0×

Where this comes from

Reported directly by Shattuck Labs, Inc. in its filing.

Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.

The official record: Shattuck Labs, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Shattuck Labs, Inc.'s shares (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Shattuck Labs, Inc.'s shares (diluted)?
Shattuck Labs, Inc. (STTK) reported shares (diluted) of 112.2M in Q1 2026.
How has Shattuck Labs, Inc.'s shares (diluted) changed year-over-year?
Shattuck Labs, Inc.'s shares (diluted) increased by 120.2% year-over-year, from 51M to 112.2M.
What is the long-term trend for Shattuck Labs, Inc.'s shares (diluted)?
Over 4 years (2021 to 2025), Shattuck Labs, Inc.'s shares (diluted) has grown at a 9.8% compound annual growth rate (CAGR), from 167.9M to 243.7M.
What does shares (diluted) mean?
The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.